ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NUVL Nuvalent Inc

68.21
-0.67 (-0.97%)
Last Updated: 11:59:28
Delayed by 15 minutes

Period:

Draw Mode:

Volume 94,394
Bid Price 68.13
Ask Price 68.30
News -
Day High 69.14

Low
34.90

52 Week Range

High
89.39

Day Low 68.07
Company Name Stock Ticker Symbol Market Type
Nuvalent Inc NUVL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.67 -0.97% 68.21 11:59:28
Open Price Low Price High Price Close Price Prev Close
69.06 68.07 69.14 68.88
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,101 94,394 $ 68.76 $ 6,490,627 - 34.90 - 89.39
Last Trade Time Type Quantity Stock Price Currency
11:59:28 100 $ 68.21 USD

Nuvalent (NUVL) Options Flow Summary

Overall Flow

Bullish

Net Premium

720k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Nuvalent Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.38B 64.07M - 0 -126.22M -1.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nuvalent News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NUVL Message Board. Create One! See More Posts on NUVL Message Board See More Message Board Posts

Historical NUVL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week67.5869.6464.4467.56373,6310.630.93%
1 Month72.8875.2261.79566.98618,663-4.67-6.41%
3 Months79.6989.3961.79575.61500,005-11.48-14.41%
6 Months52.0989.3951.5972.60474,70616.1230.95%
1 Year35.3289.3934.9060.42477,27832.8993.12%
3 Years18.1089.397.0944.63306,38450.11276.85%
5 Years18.1089.397.0944.63306,38450.11276.85%

Nuvalent Description

Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Your Recent History

Delayed Upgrade Clock